Invesco Ltd. Integra Lifesciences Holdings Corp Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Invesco Ltd. holds 3,490,908 shares of IART stock, worth $41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,490,908

Previous 3,537,207 1.31%

Holding current value

$41 Million

Previous $43.4 Million 15.26%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$11.13 - $15.99 $515,307 - $740,321	-46,299 Reduced 1.31%	3,490,908 $50 Million
Q2 2025 Aug 13, 2025	BUY	$11.6 - $21.78 $1.24 Million - $2.32 Million	106,577 Added 3.11%	3,537,207 $43.4 Million
Q1 2025 May 12, 2025	BUY	$21.13 - $26.55 $28.8 Million - $36.2 Million	1,364,345 Added 66.03%	3,430,630 $75.4 Million
Q4 2024 Feb 13, 2025	SELL	$16.95 - $26.7 $80,885 - $127,412	-4,772 Reduced 0.23%	2,066,285 $46.9 Million
Q3 2024 Nov 12, 2024	BUY	$17.14 - $31.74 $744,390 - $1.38 Million	43,430 Added 2.14%	2,071,057 $37.6 Million

Q2 2024 Aug 13, 2024	BUY	$23.14 - $34.72 $37.6 Million - $56.4 Million	1,625,373 Added 404.07%	2,027,627 $59.1 Million
Q1 2024 May 14, 2024	BUY	$33.4 - $45.2 $7.89 Million - $10.7 Million	236,375 Added 142.5%	402,254 $14.3 Million
Q4 2023 Feb 12, 2024	BUY	$34.21 - $44.59 $66,846 - $87,128	1,954 Added 1.19%	165,879 $7.22 Million
Q3 2023 Nov 13, 2023	SELL	$37.8 - $45.97 $442,373 - $537,986	-11,703 Reduced 6.66%	163,925 $6.26 Million
Q2 2023 Aug 11, 2023	BUY	$37.95 - $58.98 $93,319 - $145,031	2,459 Added 1.42%	175,628 $7.22 Million
Q1 2023 May 12, 2023	SELL	$52.61 - $60.49 $2.13 Million - $2.45 Million	-40,489 Reduced 18.95%	173,169 $9.94 Million
Q4 2022 Feb 13, 2023	BUY	$42.17 - $58.6 $1.88 Million - $2.61 Million	44,570 Added 26.36%	213,658 $12 Million
Q3 2022 Nov 14, 2022	SELL	$42.28 - $57.17 $529,641 - $716,168	-12,527 Reduced 6.9%	169,088 $7.16 Million
Q2 2022 Aug 15, 2022	BUY	$53.86 - $66.52 $1.11 Million - $1.37 Million	20,667 Added 12.84%	181,615 $9.81 Million
Q1 2022 May 16, 2022	BUY	$62.86 - $69.24 $353,461 - $389,336	5,623 Added 3.62%	160,948 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $317,972 - $372,842	-5,090 Reduced 3.17%	155,325 $10.4 Million
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $486,820 - $570,891	7,493 Added 4.9%	160,415 $11 Million
Q2 2021 Aug 17, 2021	SELL	$66.79 - $76.63 $16.9 Million - $19.4 Million	-253,173 Reduced 62.34%	152,922 $10.4 Million
Q1 2021 May 17, 2021	SELL	$62.63 - $71.15 $6.27 Million - $7.12 Million	-100,122 Reduced 19.78%	406,095 $28.1 Million
Q4 2020 Feb 16, 2021	SELL	$43.31 - $66.55 $3.56 Million - $5.47 Million	-82,136 Reduced 13.96%	506,217 $32.9 Million
Q3 2020 Nov 16, 2020	SELL	$43.33 - $51.72 $2.17 Million - $2.59 Million	-50,159 Reduced 7.86%	588,353 $27.8 Million
Q2 2020 Aug 14, 2020	BUY	$41.42 - $55.57 $21 Million - $28.1 Million	505,986 Added 381.8%	638,512 $30 Million
Q1 2020 May 15, 2020	BUY	$36.67 - $61.04 $1.38 Million - $2.3 Million	37,731 Added 39.8%	132,526 $5.92 Million
Q4 2019 Feb 14, 2020	SELL	$55.73 - $62.49 $60.7 Million - $68.1 Million	-1,090,058 Reduced 92.0%	94,795 $5.53 Million
Q3 2019 Nov 14, 2019	SELL	$53.29 - $64.59 $2.12 Million - $2.57 Million	-39,741 Reduced 3.25%	1,184,853 $71.2 Million
Q2 2019 Aug 14, 2019	BUY	$46.45 - $55.85 $859,557 - $1.03 Million	18,505 Added 1.53%	1,224,594 $68.4 Million
Q1 2019 May 15, 2019	SELL	$42.97 - $57.33 $113,870 - $151,924	-2,650 Reduced 0.22%	1,206,089 $67.2 Million
Q4 2018 Feb 14, 2019	BUY	$42.62 - $64.51 $51.5 Million - $78 Million	1,208,739 New	1,208,739 $54.5 Million

Others Institutions Holding IART

# of Institutions

229

Shares Held

79.4M

Call Options Held

19.4K

Put Options Held

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $981M
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account